Cargando…

Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs

Purpose: Lifitegrast is approved in the United States for the treatment of dry eye disease (DED). We assessed lifitegrast's ocular distribution/pharmacokinetic profile in rabbits, and (14)C-lifitegrast mass balance/excretion in dogs. Methods: Female pigmented rabbits received a single topical o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Jou-Ku, Spencer, Elizabeth, Hunt, Matthew, McCauley, Thomas, Welty, Devin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963635/ https://www.ncbi.nlm.nih.gov/pubmed/29267138 http://dx.doi.org/10.1089/jop.2017.0106

Ejemplares similares

Effect of Itraconazole on the Pharmacokinetics of Diclofenac in Beagle Dogs
por: Al-Jenoobi, Fahad I.
Publicado: (2010)

Pharmacokinetics of BMEDA after Intravenous Administration in Beagle Dogs
por: Chang, Chih-Hsien, et al.
Publicado: (2014)

Ocular pharmacokinetics of 0.45% ketorolac tromethamine
por: Attar, Mayssa, et al.
Publicado: (2010)

Preparation and pharmacokinetics in beagle dogs of ganershu sustained-release pellets
por: Pan, Jin-huo, et al.
Publicado: (2014)

Pharmacokinetic Studies of Sustained-Release Depot of Dexamethasone in Beagle Dogs
por: Blizzard, Charles, et al.
Publicado: (2016)

Pharmacokinetics of propafenone hydrochloride sustained-release capsules in male beagle dogs
por: Pan, Liping, et al.
Publicado: (2015)

Lifitegrast add-on treatment for dupilumab-induced ocular surface disease (DIOSD): A novel case report
por: Zirwas, Matthew J., et al.
Publicado: (2018)

Dry eye syndrome: developments and lifitegrast in perspective
por: Lollett, Ivonne V, et al.
Publicado: (2018)

Pharmacokinetic evaluation of Shenfu Injection in beagle dogs after intravenous drip administration
por: Zhang, Yuqiao, et al.
Publicado: (2016)

In vitro/vivo assessment of praziquantel nanocrystals: Formulation, characterization, and pharmacokinetics in beagle dogs
por: Yang, Ruyi, et al.
Publicado: (2019)

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
por: Ruan, Lan-hong, et al.
Publicado: (2021)

Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits
por: Roy Chowdhury, Uttio, et al.
Publicado: (2020)

Pharmacokinetics and Bioavailability of a Therapeutic Enzyme (Idursulfase) in Cynomolgus Monkeys after Intrathecal and Intravenous Administration
por: Xie, Hongsheng, et al.
Publicado: (2015)

Penis Allotransplantation in Beagle Dog
por: Zhao, Yongbin, et al.
Publicado: (2016)

Improved Manufacturability and In Vivo Comparative Pharmacokinetics of Dapagliflozin Cocrystals in Beagle Dogs and Human Volunteers
por: Cho, Sangho, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Immediate- and Modified-Release Mycophenolic Acid Preparations in Healthy Beagle Dogs
por: Klotsman, Michael, et al.
Publicado: (2021)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique
por: Wang, Hui-jun, et al.
Publicado: (2021)

Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs
por: Meng, Yuanyuan, et al.
Publicado: (2022)

Determination of Tropifexor in Beagle Dog Plasma by UPLC-MS/MS and Its Application in Pharmacokinetics
por: Su, Yan-Ding, et al.
Publicado: (2022)

Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beagles
por: Levionnois, Olivier Louis, et al.
Publicado: (2022)

A New Model to Describe the Single-dose Pharmacokinetics of Bevacizumab and Predict Its Multiple-Dose Pharmacokinetics in Beagle Dogs
por: Li, Meizhen, et al.
Publicado: (2019)

Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration
por: Feng, Ru, et al.
Publicado: (2018)

Comparative single-dose pharmacokinetics of sildenafil after oral and rectal administration in healthy beagle dogs
por: Yang, Hyuck-Joo, et al.
Publicado: (2018)

Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs
por: Wang, Jianzhong, et al.
Publicado: (2019)

Pharmacokinetics of intravenous administered two different high doses of ascorbic acid in healthy beagle dogs
por: Lim, Seula, et al.
Publicado: (2019)

Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies
por: Xiong, Wei, et al.
Publicado: (2021)

Rapid Colloidal Gold Immunoassay for Pharmacokinetic Evaluation of Vancomycin in the Cerebrospinal Fluid and Plasma of Beagle Dogs
por: Guo, Yechang, et al.
Publicado: (2023)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique [Corrigendum]
Publicado: (2023)

Lifitegrast: A novel drug for treatment of dry eye disease
por: Abidi, Afroz, et al.
Publicado: (2016)

Lifitegrast: a novel drug for patients with dry eye disease
por: Haber, Stacy L., et al.
Publicado: (2019)

Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes
por: Shafiee, Afshin, et al.
Publicado: (2013)

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial
por: Nichols, Kelly K, et al.
Publicado: (2018)

A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease
por: McMullin, David, et al.
Publicado: (2021)

A pharmacokinetic study of Isatin in Beagles' bodies
por: REN, AILING, et al.
Publicado: (2016)

Pharmacokinetics and Metabolism of Cyadox and Its Main Metabolites in Beagle Dogs Following Oral, Intramuscular, and Intravenous Administration
por: Sattar, Adeel, et al.
Publicado: (2016)

Pharmacokinetics of Ginkgolide B after Oral Administration of Three Different Ginkgolide B Formulations in Beagle Dogs
por: Zhao, Jie, et al.
Publicado: (2015)

Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs
por: Hwang, J.‐H., et al.
Publicado: (2017)

Pharmacokinetics and Novel Metabolite Identification of Tartary Buckwheat Extracts in Beagle Dogs Following Co-Administration with Ethanol
por: Liu, Yuancai, et al.
Publicado: (2019)

Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study
por: Wang, Meng-Jie, et al.
Publicado: (2021)

Antituberculosis Macozinone Extended-Release Tablets To Enhance Bioavailability: a Pilot Pharmacokinetic Study in Beagle Dogs
por: Koryakova, Angela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m4u60vkblbg58smnr0u2rdv0il